1. Home
  2. ACFN vs SER Comparison

ACFN vs SER Comparison

Compare ACFN & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACFN

Acorn Energy Inc.

HOLD

Current Price

$18.93

Market Cap

35.2M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.00

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACFN
SER
Founded
1986
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
29.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ACFN
SER
Price
$18.93
$3.00
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
54.1K
65.3K
Earning Date
03-05-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
473.47
N/A
EPS
2.64
N/A
Revenue
$12,630,000.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
$7.15
N/A
Revenue Growth
30.11
N/A
52 Week Low
$12.42
$1.71
52 Week High
$33.00
$7.92

Technical Indicators

Market Signals
Indicator
ACFN
SER
Relative Strength Index (RSI) 53.66 54.30
Support Level $19.60 $2.76
Resistance Level $21.50 $3.06
Average True Range (ATR) 1.58 0.29
MACD -0.08 0.12
Stochastic Oscillator 55.08 77.12

Price Performance

Historical Comparison
ACFN
SER

About ACFN Acorn Energy Inc.

Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: